| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/09/2008 | EP1594516B9 Herbal compositions for prostate conditions |
| 01/09/2008 | EP1561468B1 Pharmaceutical antidiabetic composition |
| 01/09/2008 | EP1527086B1 Compounds binding to p-selectin |
| 01/09/2008 | EP1465922B1 Corticotropin releasing factor receptor 2 agonists |
| 01/09/2008 | EP1460084B1 Novel peptide sy |
| 01/09/2008 | EP1453467A4 Methods and compositions for modulating apoptosis |
| 01/09/2008 | EP1371664B1 Wti modified peptide |
| 01/09/2008 | EP1366060B1 Method of purification of interferon-beta |
| 01/09/2008 | EP1324766B1 Fgf-2 for the treatment of peripheral artery disease |
| 01/09/2008 | EP1307237B9 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | EP1129196B1 Virulence genes and proteins, and their use |
| 01/09/2008 | EP1115416B1 Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2008 | EP1040189B1 Polypeptides, their production and use |
| 01/09/2008 | EP0988042B1 Combination of product r and an antiviral agent in the therapy of hiv infections |
| 01/09/2008 | EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/09/2008 | EP0917581B1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 01/09/2008 | EP0866726B2 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 01/09/2008 | CN101103108A HLA-binding peptides, DNA fragments encoding the same and recombinant vectors |
| 01/09/2008 | CN101102819A Prevention of thrombus formation and/or stabilization |
| 01/09/2008 | CN101102790A Identification of phospholipase A2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action |
| 01/09/2008 | CN101102789A Diagnosis and treatment of Alzheimer's disease |
| 01/09/2008 | CN101102788A Fibrosis inhibitor for implanted organ |
| 01/09/2008 | CN101102787A Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same |
| 01/09/2008 | CN101102786A Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 01/09/2008 | CN101102785A Prevention of vertical endoparasite infections |
| 01/09/2008 | CN101102784A Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease |
| 01/09/2008 | CN101102760A Methods and reagents for the treatment of immunoinflammatory disorders |
| 01/09/2008 | CN101102739A Method for delivering interferon-beta |
| 01/09/2008 | CN101100766A Preparation of nano fibre carrier for loading and slow releasing pharmaceutical and biologically active factor |
| 01/09/2008 | CN101100690A Medicine for curing diarrhea and its preparing process |
| 01/09/2008 | CN101100671A Human anti-HBsAg single-chain antibody/human antibody light chain constant region/protamine truncated recombination gene, coding protein and application |
| 01/09/2008 | CN101100665A Method for preparing animal general purpose recombinant alpha interferon |
| 01/09/2008 | CN101100664A Method for preparing recombinant canine alpha-type interferon |
| 01/09/2008 | CN101100487A Fusion protein capable of removing HPV E7 protein and its encoding gene and application |
| 01/09/2008 | CN101100483A Analogue of muramyl dipeptide |
| 01/09/2008 | CN101099861A Composition containing lactobacillus acidophilus and application thereof |
| 01/09/2008 | CN101099860A Use of erythropoietin |
| 01/09/2008 | CN101099859A New use of leuprorelin acetate in delaying senility and preventing climacteric syndrome |
| 01/09/2008 | CN101099858A Chinese medicine beauty and health product formula |
| 01/09/2008 | CN101099767A Technology for preparing 'ganjiaxinpian' |
| 01/09/2008 | CN101099731A Use of erythropoietin |
| 01/09/2008 | CN101099722A Water agent for injecting containing recombinant human serum albumin-interferon alpha fusion protein |
| 01/09/2008 | CN100360668C Recombinant calmette-Guerin bacillus vaccine for secretion of tumour necrosis factor-alpha and its constructing method |
| 01/09/2008 | CN100360665C I type aldehyde dehydrogenase of clonorchis sinensis, its coding nucleic acid and application |
| 01/09/2008 | CN100360565C Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 01/09/2008 | CN100360564C Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 01/09/2008 | CN100360563C Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 01/09/2008 | CN100360562C Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 01/09/2008 | CN100360558C Immunogenic compositions |
| 01/09/2008 | CN100360556C Hepatitis B core antigen fusion proteins |
| 01/09/2008 | CN100360555C Immunological methods and compositions for the treatment of alzheimer's disease |
| 01/09/2008 | CN100360553C Compounds and use thereof to modify transport across cell membranes |
| 01/09/2008 | CN100360184C Stable isotonic lyophilized protein formulation |
| 01/09/2008 | CN100360182C Induction of antigen specific immunologic tolerance |
| 01/09/2008 | CN100360181C Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 01/09/2008 | CN100360180C Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/09/2008 | CN100360179C Medicine for treating infantile anorexia |
| 01/09/2008 | CN100360178C Antisenescence medicine |
| 01/09/2008 | CN100360177C Medicine for treating fungal dermatitis |
| 01/09/2008 | CN100360176C Medicine for treating ulcerative colitis |
| 01/09/2008 | CN100360175C Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 01/09/2008 | CN100360174C Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 01/09/2008 | CN100360173C Lyase treatment for p. carinii |
| 01/09/2008 | CN100360126C Method for treating ischemic stroke with melatonin |
| 01/09/2008 | CN100360016C Foot disinfectant |
| 01/08/2008 | USRE40000 Method of treatment for decreasing mortality resulting from congestive heart failure |
| 01/08/2008 | US7317099 Polynucleotides encoding stem cell growth factor-like polypeptides |
| 01/08/2008 | US7317097 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 01/08/2008 | US7317096 Isolated or recombinant nucleic acid sequence encoding an (AAP-1), |
| 01/08/2008 | US7317095 Mutant glycoproteins |
| 01/08/2008 | US7317092 Nucleotide sequences coding polypeptide for use in the treatment of skin, kidney, cancer, nervous system, liver and cardiovascular disorders |
| 01/08/2008 | US7317090 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal |
| 01/08/2008 | US7317088 PRO5993 polypeptides |
| 01/08/2008 | US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof |
| 01/08/2008 | US7317086 An isolated human nucleic acid encoding a nevoid basal cell carcinoma syndrome protein, antibodies, detecting tumor protein, therapeutic treatment of tumor, cancer; genetic engineering |
| 01/08/2008 | US7317085 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 01/08/2008 | US7317081 PRO4371 polypeptides |
| 01/08/2008 | US7317077 Neural thread proteins (NTP); antiproliferative agents |
| 01/08/2008 | US7317074 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 01/08/2008 | US7317004 fusing cells: nucleic acid vector comprises a nucleotide sequence encoding a syncytium-inducing polypeptide that is expressible on a eukaryotic cell surface and comprises a sequence of a gibbon ape leukemia virus |
| 01/08/2008 | US7317003 Small peptides having anti-angiogenic and endothelial cell inhibition activity |
| 01/08/2008 | US7317002 Site-specific preparation of polyethylene glycol-GRF conjugates |
| 01/08/2008 | US7317001 Inhibiting relapse of antibiotic-associated diarrhea in a patient by administering ramoplanin in an amount and for a duration effective to inhibit relapse of antibiotic associated diarrhea in the patient |
| 01/08/2008 | US7317000 Glucose-dependent insulins |
| 01/08/2008 | US7316999 Glucose dependent release of insulin from glucose sensing insulin derivatives |
| 01/08/2008 | US7316998 Cerberus/Coco derivatives and uses thereof |
| 01/08/2008 | US7316997 GH secretagogues and uses thereof |
| 01/08/2008 | US7316996 For stimulating macrophages, for stimulating antibody synthesis, for combating infection, as an immunostimulant, in particular in relation to tumors, for preventing and treating septicaemic shock, for wound healing and as an adjuvant for vaccines |
| 01/08/2008 | US7316915 Polypeptide for use in the treatment of apoptitic disorders |
| 01/08/2008 | US7316911 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 01/08/2008 | US7316910 Rapid test for hemolytic streptococcus |
| 01/08/2008 | US7316900 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 01/08/2008 | US7316820 Applying an ethoxylated oil (Kayuuputih Eucalyptus oil, macadamia nut oil or meadow foam oil) containing 10-19 ethoxy units/molecule to reducie the appearance a varicose or spider vein or a stretch mark; nonsteroidal antiinflammatory drugs, collagen, skin brighteners (tyrosinase inhibitor) |
| 01/08/2008 | US7316819 Oral peptide pharmaceutical dosage form and method of production |
| 01/08/2008 | US7316812 Cells expressing anti-Fc receptor binding components |
| 01/08/2008 | CA2388716C Process for the purification of pharmacologically active proteins through cationic exchange chromatography |
| 01/08/2008 | CA2343713C Use of pex in the treatment of metabolic bone diseases |
| 01/08/2008 | CA2337885C Enteric coated pharmaceutical tablet and method of manufacturing |